Welcome
to the MARCH Guidelines resource site
Dear Colleagues,
I am delighted to welcome you to the MARCH Guidelines where, in case you have not heard, MARCH = Management and Awareness of the Risks of Cytotoxic Handling. This site is intended to inform and guide healthcare professionals who are involved in the preparation or administration of cytotoxic chemotherapy.
Wherever possible, the MARCH Guidelines have been constructed from the best available evidence following evaluation by an inter-disciplinary panel. They are subject to continual review and update, and I would encourage all users of the MARCH website to share new information and ideas with us so that important developments can be rapidly disseminated. We are always pleased to receive comments and feedback from users, good or bad, and of course, any constructive ideas you may have for improvement of the site.
Items of interest, current news and topical issues will be highlighted on the website, so I would encourage repeat visits to the site on a regular basis. Other valuable resources for practitioners will also be added.
On behalf of the MARCH Panel, I would like to thank our sponsors, Teva UK, for supporting this initiative in the safe handling of cytotoxic drugs. I would invite users of this site to reciprocate the support given by our sponsors and visit the Teva website.
With Best Wishes,
Professor Graham Sewell, Chair, MARCH Panel.